The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study.
Quan-Yu CaiPing YangXiao-Liang YangXiang-Hua ZhangLie-Ping GuoXin-Yuan LuLei HuoHong-Bin MaXiang-Dong WangHua-Bang ZhouLu WuNing-Yang JiaPublished in: Cancer (2023)
A decline in carbohydrate antigen 19-9 levels from elevated baseline levels should be one of the therapeutic aims of patients with intrahepatic cholangiocarcinoma who are managed with systemic therapies.
Keyphrases